FTC Order Will Ban California-based Company from COVID-19 Advertising Claims

Summary:

The Federal Trade Commission (FTC) has announced a proposed settlement with Precision Patient Outcomes, Inc. (PPO) and its CEO Margrett Priest Lewis, ordering them to stop making deceptive and unsubstantiated health claims about dietary supplements. The FTC alleges that PPO made false claims that their product, COVID Resist, could treat, prevent, or mitigate COVID-19, despite the Centers for Disease Control and Prevention (CDC) warning against making such claims. The proposed order bans PPO and Lewis from making similar claims in the future and requires them to possess and preserve scientific evidence to support future claims. This action is part of the FTC's efforts to combat COVID-related health fraud and promote consumer protection.